USPH Other Stockholder Equity vs Cash And Short Term Investments Analysis

USPH Stock  USD 97.08  1.52  1.54%   
US Physicalrapy financial indicator trend analysis is much more than just breaking down US Physicalrapy prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether US Physicalrapy is a good investment. Please check the relationship between US Physicalrapy Other Stockholder Equity and its Cash And Short Term Investments accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Other Stockholder Equity vs Cash And Short Term Investments

Other Stockholder Equity vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of US Physicalrapy Other Stockholder Equity account and Cash And Short Term Investments. At this time, the significance of the direction appears to have almost identical trend.
The correlation between US Physicalrapy's Other Stockholder Equity and Cash And Short Term Investments is 0.95. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of US Physicalrapy, assuming nothing else is changed. The correlation between historical values of US Physicalrapy's Other Stockholder Equity and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of US Physicalrapy are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Stockholder Equity i.e., US Physicalrapy's Other Stockholder Equity and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.95
Relationship DirectionPositive 
Relationship StrengthVery Strong

Other Stockholder Equity

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of US Physicalrapy balance sheet. This account contains US Physicalrapy investments that will expire within one year. These investments include stocks and bonds that can be liquidated by US Physicalrapy fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from US Physicalrapy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into US Physicalrapy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.As of now, US Physicalrapy's Enterprise Value Over EBITDA is increasing as compared to previous years. The US Physicalrapy's current Enterprise Value Multiple is estimated to increase to 20.15, while Selling General Administrative is projected to decrease to under 26.7 M.
 2021 2022 2023 2024 (projected)
Gross Profit117.2M112.0M112.0M117.6M
Total Revenue495.0M553.1M604.8M635.0M

US Physicalrapy fundamental ratios Correlations

-0.010.960.980.940.770.910.780.80.990.80.540.710.930.790.980.940.910.95-0.350.950.930.99-0.410.550.56
-0.010.020.06-0.14-0.30.23-0.28-0.09-0.02-0.090.60.44-0.330.08-0.19-0.24-0.01-0.260.41-0.26-0.26-0.08-0.50.50.5
0.960.020.930.960.750.890.70.740.970.740.50.670.890.690.940.920.840.91-0.320.880.960.93-0.380.510.52
0.980.060.930.870.630.890.670.890.950.890.510.750.90.880.920.910.970.89-0.180.880.880.95-0.460.60.61
0.94-0.140.960.870.850.840.770.680.950.680.450.580.890.590.950.940.780.95-0.430.920.970.91-0.290.420.43
0.77-0.30.750.630.850.740.920.320.820.320.490.470.780.270.870.780.480.89-0.80.890.810.81-0.260.350.36
0.910.230.890.890.840.740.750.580.920.580.760.880.780.630.870.780.750.82-0.390.830.790.89-0.70.790.8
0.78-0.280.70.670.770.920.750.40.810.40.490.550.820.40.860.730.560.87-0.810.890.750.82-0.380.460.46
0.8-0.090.740.890.680.320.580.40.741.00.150.490.80.950.730.810.970.710.140.70.740.76-0.20.340.35
0.99-0.020.970.950.950.820.920.810.740.740.570.70.910.730.980.930.860.96-0.430.960.940.99-0.410.550.55
0.8-0.090.740.890.680.320.580.41.00.740.150.490.80.950.730.810.970.710.140.70.740.76-0.20.340.35
0.540.60.50.510.450.490.760.490.150.570.150.850.310.30.480.360.350.43-0.290.450.320.53-0.740.830.83
0.710.440.670.750.580.470.880.550.490.70.490.850.570.590.630.550.650.58-0.160.590.520.67-0.90.980.98
0.93-0.330.890.90.890.780.780.820.80.910.80.310.570.740.960.950.870.96-0.430.950.950.93-0.30.420.43
0.790.080.690.880.590.270.630.40.950.730.950.30.590.740.690.720.950.650.130.660.640.77-0.320.450.46
0.98-0.190.940.920.950.870.870.860.730.980.730.480.630.960.690.960.840.99-0.50.990.960.98-0.340.470.48
0.94-0.240.920.910.940.780.780.730.810.930.810.360.550.950.720.960.880.96-0.310.950.960.93-0.240.380.39
0.91-0.010.840.970.780.480.750.560.970.860.970.350.650.870.950.840.880.82-0.010.810.810.88-0.360.50.51
0.95-0.260.910.890.950.890.820.870.710.960.710.430.580.960.650.990.960.82-0.531.00.950.96-0.290.420.43
-0.350.41-0.32-0.18-0.43-0.8-0.39-0.810.14-0.430.14-0.29-0.16-0.430.13-0.5-0.31-0.01-0.53-0.55-0.42-0.440.09-0.11-0.12
0.95-0.260.880.880.920.890.830.890.70.960.70.450.590.950.660.990.950.811.0-0.550.930.97-0.310.440.45
0.93-0.260.960.880.970.810.790.750.740.940.740.320.520.950.640.960.960.810.95-0.420.930.92-0.210.350.36
0.99-0.080.930.950.910.810.890.820.760.990.760.530.670.930.770.980.930.880.96-0.440.970.92-0.360.50.51
-0.41-0.5-0.38-0.46-0.29-0.26-0.7-0.38-0.2-0.41-0.2-0.74-0.9-0.3-0.32-0.34-0.24-0.36-0.290.09-0.31-0.21-0.36-0.97-0.97
0.550.50.510.60.420.350.790.460.340.550.340.830.980.420.450.470.380.50.42-0.110.440.350.5-0.971.0
0.560.50.520.610.430.360.80.460.350.550.350.830.980.430.460.480.390.510.43-0.120.450.360.51-0.971.0
Click cells to compare fundamentals

US Physicalrapy Account Relationship Matchups

US Physicalrapy fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets560.8M594.4M749.4M858.2M997.2M1.0B
Other Current Liab30.9M26.5M12.5M3.4M18.7M11.7M
Total Current Liabilities60.6M93.5M83.5M85.5M102.2M107.3M
Total Stockholder Equity240.3M276.2M295.6M315.8M476.2M500.0M
Property Plant And Equipment Net103.7M103.3M119.4M127.8M129.5M136.0M
Net Debt114.3M78.1M194.5M263.7M105.8M111.1M
Retained Earnings184.4M212.0M223.6M232.9M223.8M235.0M
Accounts Payable2.5M1.3M6.5M6.5M3.9M4.1M
Cash23.5M32.9M28.6M31.6M152.8M160.5M
Non Current Assets Total475.5M506.7M654.3M746.9M763.9M802.1M
Cash And Short Term Investments23.5M32.9M28.6M31.6M152.8M160.5M
Net Receivables56.1M41.9M46.3M51.9M51.9M27.3M
Common Stock Shares Outstanding12.8M12.8M12.9M13.0M14.2M12.9M
Liabilities And Stockholders Equity560.8M594.4M749.4M858.2M997.2M1.0B
Other Current Assets5.8M12.8M20.3M27.7M28.7M30.1M
Other Stockholder Equity55.8M64.0M71.1M78.7M249.5M261.9M
Total Liab181.4M184.4M297.0M373.6M345M362.3M
Property Plant And Equipment Gross103.7M103.3M97.9M208.0M214.4M225.1M
Total Current Assets85.4M87.6M95.2M111.3M233.4M245.0M
Short Long Term Debt Total137.8M111.0M223.1M295.3M258.6M271.5M
Non Currrent Assets Other1.5M1.5M(28.7M)(26.4M)2.8M3.0M
Non Current Liabilities Total120.8M90.9M213.5M288.1M242.8M255.0M
Short Term Debt27.2M59.9M61.8M75.3M78.2M82.1M
Intangible Assets52.6M56.3M86.4M108.8M109.7M115.2M
Good Will317.7M345.6M434.7M494.1M509.6M484.1M
Common Stock Total Equity148K149K150K151K173.7K144.3K
Common Stock149K150K151K152K172K147.0K
Other Assets1.5M14.1M1.6M1.6M1.9M2.1M
Long Term Debt50.4M16.6M117.6M175.8M139.0M145.9M
Property Plant Equipment22.1M21.7M119.4M127.8M146.9M154.3M
Other Liab10.2M12.3M21.7M34.3M39.5M41.5M
Net Tangible Assets7.7M6.6M(225.5M)(287.1M)(258.4M)(245.4M)
Noncontrolling Interest In Consolidated Entity930K1.4M1.5M1.6M1.4M1.3M
Retained Earnings Total Equity167.4M184.4M212.0M224.4M258.1M158.3M
Long Term Debt Total38.4M50.4M16.6M117.6M135.2M142.0M

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.75
Earnings Share
0.88
Revenue Per Share
42.489
Quarterly Revenue Growth
0.12
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.